BAMCO Inc’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,500
Closed -$670K 401
2021
Q4
$670K Sell
20,500
-96,000
-82% -$3.86M ﹤0.01% 380
2021
Q3
$4.78M Buy
+116,500
New +$4.23M 0.01% 323
2021
Q2
Sell
-28,676
Closed -$1.12M 411
2021
Q1
$1.12M Sell
28,676
-653,314
-96% -$29.4M ﹤0.01% 348
2020
Q4
$27.5M Sell
681,990
-877,007
-56% -$40.3M 0.07% 188
2020
Q3
$86.7M Buy
+1,558,997
New +$82.5M 0.27% 80

Other funds holding GDRX

BAMCO Inc's GDRX Position: Q1 2022 in Review

BAMCO Inc sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 20,500 shares — an estimated $670K sold.

BAMCO Inc first reported a position in GDRX in Q3 2020 and held it in 5 quarters. The position peaked at $86.7M in Q3 2020. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • BAMCO Inc reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • BAMCO Inc sold 20,500 GoodRx Holdings shares in Q1 2022, an estimated $670K.
  • BAMCO Inc first reported a position in GoodRx Holdings in Q3 2020 and held it in 5 quarters.
  • BAMCO Inc's GoodRx Holdings position peaked at $86.7M in Q3 2020.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on BAMCO Inc's 13F filing for Q1 2022, filed 13 May 2022.